MedTrace Logo

Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry

NCT04412655 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6609

Last updated 2020-06-11

No results posted yet for this study

Summary

The ISACS STEMI COVID-19 has been established in response to the emerging outbreak of COVID-19 to provide a European overview to estimate the real impact of COVID-19 pandemic on treatment and outcome of STEMI by primary angioplasty, and to identify any potential category of patients at risk for delay to treatment or no presentation.

Conditions

  • ST Elevated Myocardial Infarction Undergoing Mechanical Reperfusion

Interventions

DEVICE

Percutaneous Coronary Revascularization for STEMI

Percutaneous Mechanical Reperfusion for STEMI

Sponsors & Collaborators

  • Università degli Studi del Piemonte Orientale Amedeo Avogadro

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-05
Primary Completion
2020-05-30
Completion
2020-06-02

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04412655 on ClinicalTrials.gov